Viewing nowIteks Rosuvastatin Calcium Tablet 5mg
Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Teragen Itex Co., Ltd.

MFDS item code 201400286 · Approved 2014.01.22 · Insurance code 698502580
Improvement of dyslipidemia, reduction of cardiovascular disease risk, and inhibition of atherosclerosis progression
This medication is primarily used as an adjunct for patients with hypercholesterolemia, particularly those with heterozygous familial hypercholesterolemia and mixed dyslipidemia, when diet and exercise are insufficient. It is also used alongside other lipid-lowering therapies such as LDL separation techniques in patients with homozygous familial hypercholesterolemia. This medication lowers total cholesterol and LDL cholesterol levels to target levels in hypercholesterolemia patients, delaying the progression of atherosclerosis and protecting cardiovascular health. It can also help reduce total cholesterol, LDL cholesterol, and Apo-B protein levels in some pediatric patients aged 10 to 17 years who meet specific criteria. It may also be used as an adjunct to dietary therapy in patients with primary dysbetalipoproteinemia. Additionally, it is used to reduce the risk of stroke, myocardial infarction, and arterial revascularization in specific patients aged over 50 years in men and over 60 years in women who have certain cardiovascular risk factors. In summary, this medication helps improve health by addressing various types of dyslipidemia and reducing the risk of cardiovascular disease.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The starting dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is needed. 4. Patients with renal impairment: No dose adjustment is needed in patients with mild or moderate renal impairment. Do not use in patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended starting dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended starting dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) Under 10 years: Safety and efficacy have not been established.
This medication should not be used in certain patients. For instance, individuals allergic to the components of this medication, those with severely impaired liver function, those with muscle disorders, and those with severely impaired kidney function should not take this medication. Additionally, pregnant or breastfeeding women and women of childbearing age who are not using appropriate contraceptives should also avoid this medication. Patients who may be prone to muscle-related side effects should exercise caution, and high doses of this medication are contraindicated. This medication contains lactose, so individuals with lactose intolerance or related genetic disorders should not take it. Patients taking this medication should undergo regular liver function tests if they consume large amounts of alcohol or have a history of liver disease. Patients whose hypercholesterolemia is caused by hypothyroidism or nephrotic syndrome should treat the underlying conditions first. Muscle-related side effects such as myalgia, muscle weakness, myopathy, and rarely rhabdomyolysis may occur, so if any abnormal muscle symptoms arise during treatment, the physician should be informed immediately. If muscle injury markers are high in blood tests, medication may need to be discontinued. Patients with impaired kidney function or specific diseases should be monitored very carefully, and in cases of acute severe conditions, medication should be discontinued. This medication can rarely cause severe skin reactions, so if rash, itching, fever, or other symptoms appear, it should be stopped immediately and the medical staff consulted. Interactions with other medications may occur, so if other medications are being taken, this must be disclosed to the medical staff. The risk of muscle side effects may increase when used in conjunction with specific antibiotics, antifungal agents, immunosuppressants, or fibrate-class drugs. Pregnant women or those planning to become pregnant should not take this medication, and it should be stopped immediately if pregnancy occurs during treatment. Breastfeeding women are also advised to avoid this medication. In cases of overdose, there is no specific antidote, so treatment should be symptomatic and liver function and muscle damage should be assessed. Caution is advised when driving or operating machinery due to the possibility of dizziness. This medication may have higher systemic concentrations in Asians, necessitating dose adjustments. It is important to consult medical staff immediately if any unusual symptoms or suspected side effects occur during treatment.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculomotor weakness, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), morbilliform drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, ALT elevation, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air or moisture. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius. This ensures the safe maintenance of the medication's effectiveness.
Yellow round film-coated tablets
For domestic use - 30 tablets/bottle, for export - 30 tablets/box [10 tablets/(Alu-Alu X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Teragen Itex Co., Ltd.

Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Daiwoo Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Myungjin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.

Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication
TerraGen Etex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.